Cargando…

A comparative genomics analysis of lung adenocarcinoma for Chinese population by using panel of recurrent mutations

Previous studies have demonstrated that Chinese lung adenocarcinoma (LUAD) patients have unique genetic characteristics, however, the specific genomic features relating to the development and treatment of LUAD in the Chinese population are not fully understood. Here, we applied the ultra-deep target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wanlin, Wu, Min, Wang, Qianqian, Xu, Kun, Lin, Fan, Wang, Qianghu, Guo, Renhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Department of Journal of Biomedical Research 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874268/ https://www.ncbi.nlm.nih.gov/pubmed/33342770 http://dx.doi.org/10.7555/JBR.34.20200068

Ejemplares similares

Genomic Mutations of Primary and Metastatic Lung Adenocarcinoma in Chinese Patients
por: Chen, Xinyu, et al.
Publicado: (2020)

A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis
por: Zhou, Xin, et al.
Publicado: (2016)

The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations
por: Zheng, Difan, et al.
Publicado: (2016)

Efficacy and safety of afatinib in a Chinese population with advanced lung adenocarcinoma with sensitive EGFR mutations
por: Wang, Shouzheng, et al.
Publicado: (2019)

Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma
por: Li, Ying, et al.
Publicado: (2020)

Genomic alterations dissection revealed MUC4 mutation as a potential driver in lung adenocarcinoma local recurrence
por: Yuan, Chongze, et al.
Publicado: (2023)

Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population
por: Huang, Kun, et al.
Publicado: (2019)

A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations
por: Kuo, I-Ying, et al.
Publicado: (2016)

A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients
por: Zhang, Xilin, et al.
Publicado: (2020)

RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma
por: Gao, Fangyan, et al.
Publicado: (2021)

Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
por: Mitchell, Khadijah A., et al.
Publicado: (2019)

Detection and Localization of Solid Tumors Utilizing the Cancer-Type-Specific Mutational Signatures
por: Wang, Ziyu, et al.
Publicado: (2022)

A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma
por: Shen, Nan, et al.
Publicado: (2019)

Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population
por: Zhao, Ruiying, et al.
Publicado: (2021)

Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma
por: Shan, Ling, et al.
Publicado: (2015)

A novel CpG island methylation panel predicts survival in lung adenocarcinomas
por: Yan, Pingzhao, et al.
Publicado: (2019)

A novel mutation panel for predicting etoposide resistance in small-cell lung cancer
por: Qiu, Zhengang, et al.
Publicado: (2019)

Concurrent Oncogene Mutation Profile in Chinese Patients With Stage Ib Lung Adenocarcinoma
por: Wen, Ying-Sheng, et al.
Publicado: (2014)

Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma
por: Pan, Deng, et al.
Publicado: (2019)

Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers
por: Sun, Zhifu, et al.
Publicado: (2014)

Clinicopathologic and molecular characteristics of Chinese lung adenocarcinoma patients with EGFR exon 20 insertion mutations
por: Wang, Lifeng, et al.
Publicado: (2022)

Whole-genome sequencing of esophageal adenocarcinoma in Chinese patients reveals distinct mutational signatures and genomic alterations
por: Dai, James Y., et al.
Publicado: (2018)

The ChinaMAP reference panel for the accurate genotype imputation in Chinese populations
por: Li, Lin, et al.
Publicado: (2021)

MicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients
por: Zhang, Yong-Qiang, et al.
Publicado: (2016)

Comprehensive analysis of age‐related somatic mutation profiles in Chinese young lung adenocarcinoma patients
por: Yang, Bo, et al.
Publicado: (2019)

Plasma small ncRNA pair panels as novel biomarkers for early-stage lung adenocarcinoma screening
por: Dou, Yuhong, et al.
Publicado: (2018)

Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma
por: Lv, Shaogang, et al.
Publicado: (2017)

Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panel
por: Zhao, Jing, et al.
Publicado: (2022)

Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma
por: Wang, Yufei, et al.
Publicado: (2022)

A Robust Panel Based on Mitochondrial Localized Proteins for Prognostic Prediction of Lung Adenocarcinoma
por: Chen, Weifeng, et al.
Publicado: (2021)

Erratum to: Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers
por: Sun, Zhifu, et al.
Publicado: (2017)

Traditional Chinese Medicine Syndromes are Associated with Driver Gene Mutations and Clinical Characteristics in Patients with Lung Adenocarcinoma
por: Yang, Jili, et al.
Publicado: (2022)

Case Report: Outcome of Osimertinib Treatment in Lung Adenocarcinoma Patients With Acquired KRAS Mutations
por: Xiu, Weigang, et al.
Publicado: (2021)

Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology
por: Bing, Zhitong, et al.
Publicado: (2018)

Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients
por: Ding, Ying, et al.
Publicado: (2019)

The true panel of cystic fibrosis mutations in the Sicilian population
por: Chamayou, Sandrine, et al.
Publicado: (2020)

Recurrent bilateral spontaneous pneumothorax secondary to lung adenocarcinoma with epidermal growth factor receptor mutation
por: Chen, Wenhui, et al.
Publicado: (2015)

Author Correction: Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
por: Mitchell, Khadijah A., et al.
Publicado: (2020)

High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis
por: Wang, Qianqian, et al.
Publicado: (2021)

Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels
por: Kwong, Ava, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n0vg1oud24638141a4k3in2eib